Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.

PLoS One · 2014 · PMC3958406 · PMID 24642868

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

However, sex, smoking and mean platelet volume were also included as covariates because of their highly significant trends across platelet count categories combined with their possible association with VTE [13] , [20] , [21] .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.